Cadus Pharmaceutical Corp. (KDUS) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cadus Pharmaceutical Corp. (KDUS)

KDUS 1.600

0.0%

Jul 2 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: tom pope who wrote (275)	9/24/2000 1:45:27 PM
From: RCMac	Read Replies (1) of 1833

Here is the link to today's New York Times article on Icahn, "Buccaneer, or the Shareholder's Best Friend?": nytimes.com The online version doesn't have the table listing Icahn's holdings (of positions greater than $15 million), which appears in the hard copy version. (The only other biotech listed is Imclone, and he has a position in Visx.) The article gives Icahn's net worth as about $5 billion, so that his controlling 3.3 million shares of KDUS, worth under $4 million at current market, is a very tiny piece of his overall holdings. As noted, the problem will be in getting his attention focused on this grain of sand. --RCM

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next